Becton Dickinson and Company
Becton Dickinson and Company/ US0758871091 /
BDX
|
22/05/2024 22:10:00
|
Chg.
-0.41
|
Volume |
Bid10:05:50 |
Demandez à10:05:50 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
234.45USD
|
-0.17%
|
1.36 Mio.
Chiffrre d'affaires: 179.27 Mio. |
231.15Bid taille: 100 |
237.63Ask la taille: 100 |
67.76 Mrd.USD |
1.55% |
47.17 |
Description de l'entreprise
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. The innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.
Conseil d'administration & Conseil de surveillance
| PDG |
| Tom Polen |
| Conseil d'administration |
| Christopher DelOrefice, Ami Simunovich, Dave Hickey, David Shan, Elizabeth McCombs, Roland Goette, William R. Sigmund, II, Michelle Quinn, Shana Neal, Pavan Mocherla, Vishy Kanda, Michael Garrison, Denise Fleming, Tony Ezell, Richard Byrd, Herman Cueto, Jeff Silvestri |
| Conseil de surveillance |
| Tom Polen, Bertram L. Scott, Timothy M. Ring, Marshall O. Larsen, Christopher Jones, Jeffrey W. Henderson, Claire M. Fraser, R. Andrew Eckert, Carrie Byington, Catherine M. Burzik, William M. Brown, Joanne Waldstreicher |
Données de l'entreprise
| Nom: |
Becton, Dickinson and Company |
| Adresse: |
1 Becton Drive,Franklin Lakes, New Jersey 07414, USA |
| Téléphone: |
+1-201-847-6800 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.bd.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
30/09 |
| Flotte libre: |
77.40% |
| IPO date: |
23/04/1962 |
